New approaches to idiopathic neutropenia in the era of clonal hematopoiesis

Experimental Hematology & Oncology - Tập 12 - Trang 1-5 - 2023
Olisaemeka D. Ogbue1, Tariq Kewan1,2, Waled S. Bahaj1,3, Carmelo Gurnari1,4, Valeria Visconte1, Jaroslaw P. Maciejewski1
1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, USA
2Department of Hematology and Oncology, Yale University, New Haven, USA
3Division of Medical Oncology & Hematology, School of Medicine, University of Louisville, Louisville, USA
4Department of Biomedicine and Prevention, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy

Tóm tắt

Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In contrast, T cell-mediated neutropenia was the main underlying pathological mechanism among patients with T cell expansions, such as T-cell large granular lymphocytic leukemia (T-LGL) and T cell clonopathy of undetermined significance, found in 37% and 8% of cases, respectively. Patients with neutropenia also had hypogammaglobulinemia (6%) and/or monoclonal gammopathy of undetermined significance (5%). NGS application has further broadened the spectrum of causes of CIN by including manifestations of clonal hematopoiesis, present in 12% of cases. TET2 (3%), TP53 (2%), and IDH1/IDH2 (2%) mutations were the most commonly found and were enriched in cases with T-LGL. We show that these clinico-molecular associations can be simultaneously present, complicating a proper diagnostic distinction within the broader entity of seemingly idiopathic neutropenia of autoimmune origin. Identification of etiologic culprits may also guide rational selection of therapies.

Tài liệu tham khảo